English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Guardant Health
Press release submission
| May 31, 2020
GUARDANT: Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients
Trending
+
Pharmaceuticals
Patient Daily
| Jun 18, 2025
ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’
+
Pharmaceuticals
Patient Daily
| Jun 23, 2025
PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+
Pharmaceuticals
Patient Daily
| Jun 19, 2025
Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’
+
Pharmaceuticals
Patient Daily
| Jun 19, 2025
FDA loophole lets low-quality drugs from China and India flood U.S. market, while American manufacturers are held to higher standards
